These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 19027730)

  • 1. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
    Ningaraj NS; Rao MK; Black KL
    Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.
    Hu J; Ljubimova JY; Inoue S; Konda B; Patil R; Ding H; Espinoza A; Wawrowsky KA; Patil C; Ljubimov AV; Black KL
    PLoS One; 2010 Apr; 5(4):e10108. PubMed ID: 20419092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
    Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
    Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
    Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
    J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
    Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
    Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
    Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
    Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
    Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
    Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin.
    Gupta V; Su YS; Wang W; Kardosh A; Liebes LF; Hofman FM; Schönthal AH; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E20. PubMed ID: 16709026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
    Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
    Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
    Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
    PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
    Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
    Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
    Yamini B; Yu X; Gillespie GY; Kufe DW; Weichselbaum RR
    Cancer Res; 2004 Sep; 64(18):6381-4. PubMed ID: 15374943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.